ARCHIVES

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 4 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

Low-Dose Tamoxifen May Be Effective In Treating Breast Cancer, Study Finds

April 25, 2003

Cancer Mortality By County For 1950-69 Now Available From GPO; Price-$9

April 26, 1974

New Ultrasound Technique For Hard To Diagnose Cysts

June 29, 2001

Neutron Answers Needed Soon, Kligerman Says

May 6, 1983

Ohio State Breaks Ground For $1 Billion Expansion Of Medical Center, Cancer Hospital

June 18, 2010